rct
    2011
    High Quality

    Selenium and the Course of Mild Graves' Orbitopathy

    Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Wiersinga WM

    Published in New England Journal of Medicine

    Key Findings

    Sodium selenite 200 mcg/day for 6 months improved quality of life, reduced eye involvement and slowed progression of mild Graves' orbitopathy versus placebo.

    Conclusions

    Selenium supplementation benefits patients with mild Graves' orbitopathy in a marginally selenium-deficient population.

    Supplements Studied

    Selenium
    Mineral

    Selenium administration significantly improved quality of life, reduced ocular involvement, and slowed progression of the disease in patients with mild Graves' orbitopathy.

    Related Health Concerns

    Study Details

    Year:2011
    Sample Size:159
    Quality Score:9/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.